Cargando…

Challenging Differential Diagnosis of Hypergastremia and Hyperglucagonemia with Chronic Renal Failure: Report of a Case with Multiple Endocrine Neoplasia Type 1

A 53-year-old woman developed end-stage renal failure during a 15-year clinical course of primary hyperparathyroidism and was referred to our hospital for evaluation of suspected multiple endocrine neoplasia type 1 (MEN1). Genetic testing revealed a novel deletion mutation at codon 467 in exon 10 of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Murakami, Takaaki, Usui, Takeshi, Nakamoto, Yuji, Nakajima, Akio, Mochida, Yuki, Saito, Sumio, Shibayama, Takahiro, Yamazaki, Nobuhisa, Hatoko, Tomonobu, Kato, Tomoko, Yonemitsu, Shin, Muro, Seiji, Oki, Shogo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Japanese Society of Internal Medicine 2017
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5498202/ https://www.ncbi.nlm.nih.gov/pubmed/28566601 http://dx.doi.org/10.2169/internalmedicine.56.7230

Ejemplares similares

Syndrome of Inappropriate Antidiuretic Hormone Secretion Associated with Amyotrophic Lateral Sclerosis in a Patient Developing Carbon Dioxide Narcosis
por: Inoue, Yui, et al.
Publicado: (2017)

OR24-4 Targeting Hyperglucagonemia Reverses Glucagon Resistance
por: Bernal-Mizrachi, Ernesto, et al.
Publicado: (2022)

A case of multiple glucagonomas with no clinical manifestations of excess glucagon despite hyperglucagonemia
por: Amano, Shogo, et al.
Publicado: (2023)

Liraglutide administration in type 2 diabetic patients who either received no previous treatment or were treated with an oral hypoglycemic agent showed greater efficacy than that in patients switching from insulin
por: Nambu, Takuo, et al.
Publicado: (2013)

Partial Inhibition of Insulin Secretion Results in Glucose Intolerance but Not Hyperglucagonemia
por: Ramanathan, Ranjani P., et al.
Publicado: (2011)

Hyperglucagonemia in Pediatric Adiposity Associates With Cardiometabolic Risk Factors but Not Hyperglycemia
por: Stinson, Sara E, et al.
Publicado: (2022)

Determinants of hyperglucagonemia in pediatric non-alcoholic fatty liver disease
por: Maruszczak, Katharina, et al.
Publicado: (2022)

A Novel p.L145Q Mutation in the HNF1B Gene in a Case of Maturity-onset Diabetes of the Young Type 5 (MODY5)
por: Kato, Tomoko, et al.
Publicado: (2018)

Association of Basal Hyperglucagonemia with Impaired Glucagon Counterregulation in Type 1 Diabetes
por: Farhy, Leon S., et al.
Publicado: (2012)

Glucagon Resistance and Decreased Susceptibility to Diabetes in a Model of Chronic Hyperglucagonemia
por: Bozadjieva Kramer, Nadejda, et al.
Publicado: (2021)

Effects of Acute Hyperglucagonemia on Hepatic and Intestinal Lipoprotein Production and Clearance in Healthy Humans
por: Xiao, Changting, et al.
Publicado: (2011)

Hyperglucagonemia in an animal model of insulin- deficient diabetes: what therapy can improve it?
por: Barbetti, Fabrizio, et al.
Publicado: (2016)

Time-dependent effects of endogenous hyperglucagonemia on glucose homeostasis and hepatic glucagon action
por: Lubaczeuski, Camila, et al.
Publicado: (2023)

Multiple Endocrine Neoplasia
por: Heath, David
Publicado: (1998)

Evidence That in Uncontrolled Diabetes, Hyperglucagonemia Is Required for Ketosis but Not for Increased Hepatic Glucose Production or Hyperglycemia
por: Meek, Thomas H., et al.
Publicado: (2015)

Pancreatic α-cell hyperplasia and hyperglucagonemia due to a glucagon receptor splice mutation
por: Larger, Etienne, et al.
Publicado: (2016)

Pathways of Glucagon Secretion and Trafficking in the Pancreatic Alpha Cell: Novel Pathways, Proteins, and Targets for Hyperglucagonemia
por: Asadi, Farzad, et al.
Publicado: (2021)

Multiple endocrine neoplasia type 2
por: Marini, Francesca, et al.
Publicado: (2006)

Multiple endocrine neoplasia type 1
por: Marini, Francesca, et al.
Publicado: (2006)

The Hirschsprung's–multiple endocrine neoplasia connection
por: Moore, Sam W., et al.
Publicado: (2012)

Multiple endocrine neoplasia: the Chilean experience
por: Diaz, René E., et al.
Publicado: (2012)

Multiple endocrine neoplasia type 1
por: Thakker, R. V.
Publicado: (2012)

Multiple endocrine neoplasia 2: an overview
por: Saravana-Bawan, B, et al.
Publicado: (2022)

Pseudo‐hyperglucagonemia was observed in pancreatectomized patients when measured by glucagon sandwich enzyme‐linked immunosorbent assay
por: Kobayashi, Masaki, et al.
Publicado: (2020)

Extra-endocrine phenotypes at infancy in multiple endocrine neoplasia type 2B: A case series of six Japanese patients
por: Matsushita, Rie, et al.
Publicado: (2021)

Postabsorptive hyperglucagonemia in patients with type 2 diabetes mellitus analyzed with a novel enzyme‐linked immunosorbent assay
por: Matsuo, Toshihiro, et al.
Publicado: (2015)

Multiple endocrine neoplasias: an overview of recent progress
por: Rocha-e-Silva, Mauricio, et al.
Publicado: (2012)

Recurrent Pheochromocytoma, as Component of Multiple Endocrine Neoplasia
por: Dominguez, Hydelene Beray, et al.
Publicado: (2021)

Surgical treatment of pancreatic endocrine tumors in multiple endocrine neoplasia type 1
por: Machado, Marcel Cerqueira Cesar
Publicado: (2012)

Chromosome 3p alterations in pancreatic endocrine neoplasia
por: Amato, Eliana, et al.
Publicado: (2010)

Multiple endocrine neoplasia type 1 and adrenal Cushing's
por: Vithian, Karunakaran, et al.
Publicado: (2011)

Telomere dysfunction suppresses multiple endocrine neoplasia in mice
por: Lee, Ji-Hyeon, et al.
Publicado: (2014)

Imaging diagnostic standard in multiple endocrine neoplasia (MEN)
por: Tesdorff, J, et al.
Publicado: (2014)

Multiple endocrine neoplasia and primary hyperparathyroidism – practical approach
por: Koza, Jarosław
Publicado: (2015)

Multiple endocrine neoplasia 1: a broad overview
por: Thompson, Rachel, et al.
Publicado: (2021)

Case Report: A Case of Moyamoya Syndrome Associated With Multiple Endocrine Neoplasia Type 2A
por: Matano, Fumihiro, et al.
Publicado: (2021)

Lung adenocarcinoma and adrenocortical carcinoma in a patient with multiple endocrine neoplasia type 1
por: Ohara, Nobumasa, et al.
Publicado: (2016)

Low-dose Selective Arterial Calcium Stimulation Test for Localizing Insulinoma: A Single-center Experience of Five Consecutive Cases
por: Hatoko, Tomonobu, et al.
Publicado: (2020)

Cutaneous lesions and other non-endocrine manifestations of Multiple Endocrine Neoplasia type 1 syndrome
por: Pierotti, Laura, et al.
Publicado: (2023)

Clinicopathological features and menin expression of pancreatic neuroendocrine neoplasm associated with multiple endocrine neoplasia type 1
por: Sonoda, Akari, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1dr4kq84fajue5imph9jdnlogr